GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Changmao Biochemical Engineering Co Ltd (HKSE:00954) » Definitions » Capex-to-Revenue

Changmao Biochemical Engineering Co (HKSE:00954) Capex-to-Revenue : 0.25 (As of Jun. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Changmao Biochemical Engineering Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Changmao Biochemical Engineering Co's Capital Expenditure for the six months ended in Jun. 2023 was HK$-80.01 Mil. Its Revenue for the six months ended in Jun. 2023 was HK$324.42 Mil.

Hence, Changmao Biochemical Engineering Co's Capex-to-Revenue for the six months ended in Jun. 2023 was 0.25.


Changmao Biochemical Engineering Co Capex-to-Revenue Historical Data

The historical data trend for Changmao Biochemical Engineering Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changmao Biochemical Engineering Co Capex-to-Revenue Chart

Changmao Biochemical Engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.18 0.46 0.31 -

Changmao Biochemical Engineering Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.43 0.31 0.30 0.25 -

Competitive Comparison of Changmao Biochemical Engineering Co's Capex-to-Revenue

For the Specialty Chemicals subindustry, Changmao Biochemical Engineering Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Changmao Biochemical Engineering Co's Capex-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Changmao Biochemical Engineering Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Changmao Biochemical Engineering Co's Capex-to-Revenue falls into.



Changmao Biochemical Engineering Co Capex-to-Revenue Calculation

Changmao Biochemical Engineering Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-249.607) / 815.24
=0.31

Changmao Biochemical Engineering Co's Capex-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-80.009) / 324.424
=0.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changmao Biochemical Engineering Co  (HKSE:00954) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Changmao Biochemical Engineering Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Changmao Biochemical Engineering Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Changmao Biochemical Engineering Co (HKSE:00954) Business Description

Traded in Other Exchanges
N/A
Address
No. 1228 Chang Jiang Bei Road, New North Zone, Jiangsu Province, Changzhou City, CHN, 213034
Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.

Changmao Biochemical Engineering Co (HKSE:00954) Headlines

No Headlines